# Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee

> **NCT02183129** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 91 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Meloxicam

## Key facts

- **NCT ID:** NCT02183129
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04-01
- **Primary completion:** 1999-11-01
- **Final completion:** —
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183129, "Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02183129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*